InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,329.84
(
0.20%
)
US TECH 100
17,936.00
(
0.07%
)
Dow Jones
39,462.48
(
0.04%
)
Brent Oil
79.50
(
0.97%
)
Bitcoin
60,377.19
(
-2.20%
)
Post# of 252816
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 834
Posts 120246
Boards Moderated 18
Alias Born 09/05/2002

DewDiligence

Member Level

Re: microcapfun post# 111483

Saturday, 12/25/2010 11:54:52 PM

Saturday, December 25, 2010 11:54:52 PM

Post# of 252816

INCY—I think…050 would be unlikely to beat tasocitinib head to head, given the data reported thus far.

INCY’s drug might be able to show statsig non-inferiority, which ought to be good enough for FDA approval with a suitable SPA.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up